Skip to main content
. 2021 Jan 22;11(1):e043564. doi: 10.1136/bmjopen-2020-043564

Table 1.

Baseline characteristics of randomised participants

Tourniquet inflated,
n=27
Tourniquet not inflated,
n=26
All participants,
n=53
Background information available (n, %) 25 (93) 24 (92) 49 (93)
Study knee (left; n, %) 14 (56) 12 (50) 26 (53)
Age at study registration (in years; mean, SD) 69.4 (6.9) 67.5 (6.8) 69.4 (6.9)
Sex (female; n, %) 11 (41) 13 (50) 24 (45)
BMI (kg/m2)
 Mean, SD 30.5 (5.5) 30.6 (5.2) 30.6 (5.3)
 Missing 1 (4) 1 (4) 2 (4)
 Current smoker (yes; n, %) 1 (4) 0 1 (2)
Weekly alcohol consumption (n, %)
 0 9 (36) 12 (50) 21 (43)
 1–7 11 (44) 7 (29) 18 (37)
 8–14 3 (12) 1 (4) 4 (8)
 15–21 1 (4) 2 (8) 3 (6)
 More than 21 1 (4) 1 (4) 2 (4)
 Missing 0 1 (4) 1 (2)
Previous DVT, PE or VTE (yes; n, %) 2 (8) 1 (4) 3 (6)
Previous cerebrovascular accident/stroke (n, %)
 No 25 (100) 22 (92) 47 (96)
 Yes 0 1 (4) 1 (2)
 Missing 0 1 (4) 1 (2)
Taking blood thinning medication (n, %)
 No 20 (80) 17 (71) 37 (76)
 Yes 5 (20) 6 (25) 11 (22)
 Missing 0 1 (4) 1 (2)
Previous surgery/injury to study knee (yes, n, %) 12 (48) 12 (50) 24 (49)
Hospital location (n, %)
 University Hospital 3 (11) 4 (15) 7 (13)
 Rugby St Cross 24 (89) 22 (85) 46 (87)
Baseline MRI lesion category (n, % per group)
 None 3 (12.5) 3 (11.5) 6 (11)
 Less than 10 lesions 8 (33.3) 9 (34.6) 17 (32)
 10–30 lesions 6 (25.0) 8 (30.8) 14 (26)
 Over 10 lesions with significant atrophy 7 (29.2) 4 (15.4) 11 (21)
 Over 30 lesions with significant atrophy 0 2 (7.7) 2 (4)
 Missing 3 (11%) 0 3 (6)

BMI, body mass index; DVT, deep vein thrombosis; PE, Pulmonary Embolism; SVT, symptomatic venous thromboembolism.